01/02/2013 | Press release

Geron to Present at the J.P. Morgan Healthcare Conference

distributed by noodls on 01/02/2013 17:14

Print Print

Sharing and Personal Tools

Geron to Present at the J.P. Morgan Healthcare Conference

MENLO PARK, Calif., January 2, 2013 - Geron Corporation (Nasdaq: GERN) today announced that John A. Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at 1:00 p.m. Pacific Time on Thursday, January 10, at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco.

A live webcast of the audio and slide presentation, including Q&A session, will be available at http://jpmorgan.metameetings.com/webcasts/healthcare13/directlink?ticker=GERN. Following the live presentation, the webcast will be archived and available for replay at the same address for a period of 30 days.

About Geron

Geron is a biopharmaceutical company developing first-in-class therapies for cancer, including its telomerase inhibitor, imetelstat. For more information about Geron, visit www.geron.com.

CONTACT:

Anna Krassowska, Ph.D.
Investor and Media Relations
650-473-7765
investor@geron.com
media@geron.com

###

HUG#1667881

Back

View original format